QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 191 filers reported holding QIAGEN NV in Q4 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $14,700,000 | +25.8% | 535,700 | 0.0% | 0.48% | +12.9% |
Q2 2016 | $11,684,000 | -32.5% | 535,700 | -30.9% | 0.43% | -32.4% |
Q1 2016 | $17,314,000 | -40.4% | 775,000 | -26.3% | 0.63% | -36.9% |
Q4 2015 | $29,060,000 | +7.2% | 1,051,000 | 0.0% | 1.00% | +18.9% |
Q3 2015 | $27,116,000 | +4.1% | 1,051,000 | 0.0% | 0.84% | +13.8% |
Q2 2015 | $26,054,000 | -1.6% | 1,051,000 | 0.0% | 0.74% | -2.6% |
Q1 2015 | $26,485,000 | +36.5% | 1,051,000 | +27.1% | 0.76% | +33.9% |
Q4 2014 | $19,401,000 | +3.0% | 827,000 | 0.0% | 0.57% | -2.6% |
Q3 2014 | $18,831,000 | -6.9% | 827,000 | 0.0% | 0.58% | -1.5% |
Q2 2014 | $20,220,000 | +15.9% | 827,000 | 0.0% | 0.59% | +25.5% |
Q1 2014 | $17,441,000 | -11.4% | 827,000 | 0.0% | 0.47% | -7.1% |
Q4 2013 | $19,691,000 | +11.3% | 827,000 | 0.0% | 0.51% | +7.7% |
Q3 2013 | $17,698,000 | -2.7% | 827,000 | -9.5% | 0.47% | -10.3% |
Q2 2013 | $18,194,000 | – | 913,800 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Exane Asset Management | 630,990 | $17,371,542,000 | 5.45% |
Tikvah Management LLC | 369,425 | $10,137,000 | 5.29% |
Hardman Johnston Global Advisors LLC | 3,786,208 | $103,894,000 | 4.73% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 300,000 | $8,232,000 | 4.50% |
HealthCor Management, L.P. | 2,275,000 | $62,426,000 | 3.80% |
Opus Point Partners Management, LLC | 110,565 | $3,034,000 | 1.70% |
Douglas Lane & Associates, LLC | 1,847,676 | $50,700,000 | 1.35% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,854,629 | $78,331,000 | 1.20% |
C M BIDWELL & ASSOCIATES LTD | 144,340 | $3,961,000 | 0.94% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,471,580 | $40,380,000 | 0.94% |